Mandate

Vinge advises Edgeware AB (publ) in connection with listing on Nasdaq Stockholm

December 14, 2016

 Vinge has advised Edgeware AB (publ) (“Edgeware”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on 29 November 2016 and the first day of trading on Nasdaq was 9 December 2016. The offer price was set at SEK 29 per share, which corresponded to a market value for the total number of shares in the company of approximately MSEK 870. The total value of the offering amounted to MSEK 450 provided an overallotment option was exercised in its entirety.
 
Edgeware was founded in 2004 and has since evolved into a global, high-tech company that develops and offers hardware and software systems as well as associated services that enable effective and scalable TV and video streaming over IP. The Company’s solutions are primarily sold to telecom and cable operators as well as broadcasters and content owners that want to efficiently, securely and cost-efficiently make TV and video content available to their viewers.
 
Vinge’s team primarily consisted of Johan Larsson, Jesper Schönbeck, Rikard Lindahl, Johan Mattson, Amanda Knutsson, Malte Hedlund and Michaela Cronemyr. Tora Hansjons, Emilie Parland and Maria Schultzberg advised on tax issues.

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025